21 CFR 528.1092

§ 528.1092 opAFP-GHc2 recombinant deoxyribonucleic acid construct.

United States · 21 CFR — Food and Drugs · Status: effective

Cite this

Citation: 21 CFR 528.1092, § 528.1092 opAFP-GHc2 recombinant deoxyribonucleic acid construct, United States, version 1 as recorded 2026-07-09, yourstate.us, https://yourstate.us/provision/87676
Permanent ID: ys:prov:87676@1
SHA-256: 4ea696a61d8e5175805ff41ac045cac68c6159418eab48604a4cab9db973bb07

The hash is SHA-256 of this version's text, with every run of whitespace collapsed to a single space and the ends trimmed. The ID always leads back here, and checking it says whether the text you cited is still the current version.

Full text

(a) Specifications. A single copy of the α-form of the opAFP-GHc2 recombinant deoxyribonucleic acid (rDNA) construct at the α-locus in the EO-1 α lineage of triploid, hemizygous, all-female Atlantic salmon (Salmo salar). (b) Sponsor. See No. 086053 in § 510.600 of this chapter. (c) Indications for use. Significantly more of these Atlantic salmon grow to at least 100 grams within 2,700 Celsius degree-days than their comparators. (d) Limitations. These Atlantic salmon are produced as eyed-eggs and grown-out only in physically-contained, freshwater culture facilities specified in an FDA-approved application.

Legislative history

This is a federal regulation, adopted through agency rulemaking under the Administrative Procedure Act — not enacted by a recorded vote of Congress.